Managing Director Of Sun Pharmaceuticals

Rediff.com » News » Managing Director Of Sun Pharmaceuticals

News for Managing Director Of Sun Pharmaceuticals

News
Business

Air India to resume flights to Shanghai from Feb 2026

Air India announced the resumption of its non-stop flights between Delhi and Shanghai (PVG), effective from February 1, 2026, marking Air India's return to mainland China after nearly six years, an......

Cough Medicine Deaths: Rajasthan Suspends Drug Controller

The Rajasthan government has suspended the state drug controller and halted the distribution of medicines manufactured by Jaipur-based company Kaysons Pharma, officials said. Kindly note the image......

15 killed, 34 hurt in explosion at Telangana pharma plant

Fifteen people died and 34 persons suffered injuries in the explosion at the Sigachi Industries' pharma plant in Telangana's Sangareddy district, state health minister C Damodar Rajanarasimha said......

Budget Prepares For Rise In Cancer Cases

Do we have enough trained oncologists and medical professionals in India to man these over 4,500 beds in the public sector? IMAGE: Union Home Minister Amit A Shah at the Shri Mahavir Health and......

'Ladakh Made The World Wary Of China'

'While my generation carries with it the memory of the Chinese perfidy of 1962, this generation will carry the memory of Chinese perfidy in Galwan.' IMAGE: Dhruv and Cheetal helicopters showcase......

Cipla Q2 profit up 3.7% at Rs 1,353 cr

Pharma major Cipla Ltd on Thursday reported a 3.7 per cent rise in consolidated net profit at Rs 1,353.37 crore for the second quarter ended September 30, 2025. Photograph: Danish Siddiqui/Reuters......

Sun Pharma Q2 net profit up 3% at Rs 3,118 cr

Sun Pharmaceutical Industries on Wednesday posted a 2.56 per cent increase in its consolidated net profit to Rs 3,118 crore for the second quarter ended September 30, aided by robust sales in India......

Samvat 2082: Investors likely to see up to 15% returns from equities

After a year of modest returns, equity investors may anticipate gains of 10-15 per cent in Samvat 2082, which began on October 21. IMAGE: Sundararaman Ramamurthy, MD & CEO, BSE rings the bell......

USFDA's new draft biosimilar rules to benefit Indian biotech cos

The US Food and Drug Administration’s (USFDA)’s new draft guidelines aimed at speeding up and reducing the cost of developing biosimilars — lower-priced, near-replicas of complex biologic......

Mankind taps OpenAI to institutionalise AI in ops

Delhi-based pharma major Mankind Pharma on Wednesday announced a collaboration with OpenAI to institutionalise artificial intelligence (AI) across its value chain, making it one of the first few......

Managing Director Of Sun Pharmaceuticals

News for Managing Director Of Sun Pharmaceuticals

Air India to resume flights to Shanghai from Feb 2026

Cough Medicine Deaths: Rajasthan Suspends Drug Controller

15 killed, 34 hurt in explosion at Telangana pharma plant

Budget Prepares For Rise In Cancer Cases

'Ladakh Made The World Wary Of China'

Cipla Q2 profit up 3.7% at Rs 1,353 cr

Sun Pharma Q2 net profit up 3% at Rs 3,118 cr

Samvat 2082: Investors likely to see up to 15% returns from equities

USFDA's new draft biosimilar rules to benefit Indian biotech cos

Mankind taps OpenAI to institutionalise AI in ops

Top Coverage News

World Test Championship 2023

Manipur's Tragedy

IPL 2023

Sri Lanka's Tour of India 2023

GUJARAT, HIMACHAL GO TO POLLS